SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Alexion Pharmaceuticals, Inc. (ALXN)

ALXN RSS Feed
Add ALXN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 11/4/2016 6:53:24 PM - Followers: 4 - Board type: Free - Posts Today: 0

http://www.alexionpharm.com/

http://finance.yahoo.com/q/ks?s=ALXN

Alexion Pharmaceuticals, Inc., a biotechnology company, develops and delivers life-changing drug therapies for patients with serious and life-threatening medical conditions. It primarily engages in the discovery, development, and commercialization of biologic therapeutic products for the treatment of severe disease states, including hematologic diseases, cancer, and autoimmune disorders. The company markets Soliris (eculizumab) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disorder in the United States and Europe. It also is evaluating other potential indications for Soliris, as well as other formulations of eculizumab for additional clinical indications. In addition, it is developing antibody product candidates targeting the treatment of patients with severe unmet medical needs. The company's drug programs comprise DC-SIGN Mab, a cancer Vaccine; Eculizumab (intravitreal) for age-related macular degeneration; and Eculizumab (intravenous) for myasthenia gravis and multifocal motor neuropathy, which are under preclinical development stage; CD200 Mab for the treatment of chronic lymphocytic leukemia and multiple myeloma under Phase I clinical trial; and Eculizumab (intravenous) under Phase I/II clinical trial for the treatment of asthma. . Alexion Pharmaceuticals was founded in 1992 and is headquartered in Cheshire, Connecticut.

 

 

Headquartered in Cheshire, Connecticut, Alexion employs more than 700 people around the world. In addition to our corporate headquarters, Alexion’s facilities include a manufacturing plant in Smithfield, Rhode Island, EMEA (Europe, Middle East & Africa) regional headquarters in Lausanne, Switzerland, a European shared service center in Paris, distribution and sales operations in major markets throughout Europe, and new operations in Tokyo, Japan, Sydney, Australia, São Paulo, Brazil, Ontario, Canada and other countries. The company is also expanding its reach in Latin America, the Middle East and Africa.

Alexion’s global presence reflects the approval of Soliris for the treatment of patients with PNH in the United States, 29 European countries, Australia, Canada and other countries. The company is working toward seeking regulatory approval in other countries of Asia and South America.


 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALXN
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ALXN News: Lifshitz & Miller Law Firm Announces Investigation of Alexion Pharmaceuticals, Inc., Blue Nile, Inc., Hill International, Inc... 12/01/2016 11:45:00 AM
ALXN News: Alexion to Present at the Citi 2016 Global Healthcare Conference 11/29/2016 10:00:00 AM
ALXN News: Lawsuit for Investors in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares announced by Shareholders Foundation 11/29/2016 09:45:00 AM
ALXN News: SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. ... 11/25/2016 08:00:00 PM
ALXN News: Robbins Arroyo LLP: Alexion Pharmaceuticals, Inc. (ALXN) Misled Shareholders According to a Recently Filed Class Action 11/22/2016 03:59:00 PM
PostSubject
#86   BUYOUT RUMORS Inthe203 11/04/16 06:53:24 PM
#85   ALXN bullish 132.135 stocktrademan 08/19/16 04:16:42 PM
#84   HEADS UP! BUYOUT/HOSTILE TAKEOVER! Inthe203 06/26/16 02:44:13 PM
#83   Here’s Our Highlight From the Latest Alexion Pharmaceuticals venturecapp 05/04/16 01:10:49 PM
#82   Here’s how to get an Exposure to Moderna’s trendmkr 01/12/16 12:09:08 PM
#81   U.S JUSTICE DEPARTMENT INVESTIGATING ALEXION nyc212investor 11/04/15 12:12:29 PM
#80   A look at the charts for you.... 123tom 10/29/15 03:04:11 PM
#79   Tomorow is all about the financials. nyc212investor 10/28/15 12:53:54 PM
#78   KANUMA DRUG TO BE APPROVED nyc212investor 10/23/15 05:32:15 PM
#77   ALEXION LOOKING TO EXPAND nyc212investor 10/23/15 05:28:10 PM
#76   CONGRATULATIONS ALEXION! nyc212investor 10/23/15 05:22:08 PM
#75   $ALXN recent news/filings stocktrademan 05/08/15 10:21:03 AM
#74   I still believe they'll do well in the Axel 05/07/15 05:13:38 AM
#73   Major beat down today! Overpaid for GEVA. crudeoil24 05/06/15 09:45:21 AM
#72   Hell of a chart here! 90% success when Axel 05/02/15 04:06:28 PM
#71   Closed above 190. > ALL TIME HIGH! crudeoil24 10/24/14 06:13:03 PM
#70   I'm curious to see what they are doing KarinCA 03/22/14 08:25:08 PM
#69   ALXN Weekly Chart: the 3rd week of Oct. ospreyeye 11/10/13 02:06:41 AM
#68   Soliris® (eculizumab) Inhibits TMA and Improves Renal Function ospreyeye 11/10/13 01:57:55 AM
#67   Q3 details ECole 10/25/13 05:30:52 AM
#66   Earnings reported on 10/24 before market opening. ChasinProfit 10/21/13 11:34:49 AM
#65   Possible Roche takeover mkinhaw 07/30/13 02:21:01 PM
#64   Alxn - wtf just happened wow gixxer11 07/30/13 02:08:49 PM
#63   Wells Fargo Conference ECole 07/12/13 10:48:55 AM
#62   http://alxn.newshq.businesswire.com/news surf1944 06/11/13 01:11:13 PM
#61   7:33AM Alexion Pharma received a Warning Letter from surf1944 03/28/13 08:41:46 AM
#60   !!!TIMBER!!!! madmanmartinwins 01/23/13 03:08:17 PM
#59   Alexion Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (ALXN) surf1944 01/18/13 10:28:23 AM
#58   6:36AM Alexion Pharma beats by $0.13, reports revs surf1944 10/24/12 12:01:00 PM
#57   6:36AM Alexion Pharma beats by $0.11, beats on surf1944 07/25/12 08:46:15 AM
#56   12:40AM Alexion Pharma presents data show majority of surf1944 06/18/12 08:56:58 AM
#55   <<< $ALXN Links! >>> ~ MAC's Quick DD Penny Roger$ 04/24/12 01:43:13 AM
#54   ~ Tuesday! $ALXN ~ Q1 Earnings posted, pending Penny Roger$ 04/24/12 01:41:55 AM
#53   Alexion (ALXN), with its only product Soliris, bases surf1944 04/11/12 09:26:37 AM
#52   ~ $ALXN ~ Earnings posted, pending or coming Penny Roger$ 02/06/12 04:11:11 AM
#51   ALXN 3 years chart stocktrader001 01/13/12 04:22:58 AM
#50   Alexion Pharmaceuticals, Inc. (ALXN): While the number of surf1944 01/08/12 08:30:35 PM
#49   Alexion Pharma: Longer-term data on Soliris showed significant mlkrborn 11/10/11 03:51:02 PM
#48   6:38AM Alexion Pharma beats by $0.09, beats on surf1944 10/20/11 07:37:05 AM
#47   Ready? Then up now! Its all setted... lady glueck 10/06/11 07:53:12 AM
#46   Alexion Pharma ALXN Oppenheimer Outperform $63 » $74 surf1944 09/27/11 07:32:38 AM
#45   surf1944. ALXN. New Drug Approval: PoemStone 09/25/11 10:00:01 PM
#44   News: Alexion Pharmaceuticals, Inc. has revised its 2011 Quaaflac 09/23/11 01:42:38 PM
#43   Nice break-out $63. Quaaflac 09/15/11 12:33:14 PM
#42   An Uncommon Sense Growth Strategy For Bull And surf1944 09/04/11 12:00:31 PM
#41   Alexion Pharma ALXN Brean Murray Buy $57 » $60 surf1944 07/21/11 08:58:25 PM
#40   Top 10 list of unusual option activity surf1944 07/20/11 11:13:18 PM
#39   Researchers Present Final Data from Phase 2 Studies surf1944 06/17/11 09:12:15 AM
#38   Alexion Cites Positive Soliris Data surf1944 06/17/11 09:11:32 AM
#37   1:50AM Alexion Pharma present final data from Phase surf1944 06/13/11 09:38:53 AM
PostSubject